Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis

Yanwei Qiao1, Xuequn Zhao1, Jun Liu1

  • 1Department of Infectious Disease, Tianjin First Center Hospital, Tianjin, China.

Bioengineered
|November 1, 2019
PubMed

Insights

Epstein-Barr virus (EBV) circular RNAs (circRNAs) sponge microRNAs (miRNAs), leading to increased expression of target genes. This mechanism contributes to the development of EBV-associated human cancers.

Area of Science:

  • Virology
  • Molecular Biology
  • Oncology

Background:

  • Epstein-Barr virus (EBV) is a widespread oncogenic virus implicated in numerous human cancers.
  • EBV proteins and miRNAs are known contributors to malignancy.
  • Circular RNAs (circRNAs) encoded by EBV have recently been identified.

Purpose of the Study:

  • To investigate the functional role of EBV-encoded circRNAs in EBV-associated malignancies.
  • To elucidate the mechanism by which EBV circRNAs influence gene expression and cellular processes.

Main Methods:

  • R-resistance RNA sequencing (RNA-seq) to identify EBV circRNAs.
  • miRNA sequencing (miRNA-seq) to detect miRNA expression in EBV-infected cells.
  • Bioinformatic analysis to construct regulatory networks between circRNAs, miRNAs, and target genes.

Main Results:

  • A total of 56 miRNAs were identified as being sponged by the EBV circRNAome.
  • EBV infection led to the down-regulation of 18 and 5 miRNAs in host B and epithelial cells, respectively.
  • A regulatory network involving five miRNAs and 1414 target genes was constructed, with most targets up-regulated in EBV-infected cells.

Conclusions:

  • EBV circRNAs act as miRNA sponges, promoting the up-regulated expression of their target genes.
  • This circRNA-miRNA-target axis plays a significant role in the pathogenesis of EBV-associated malignancies.
  • These findings provide novel insights into the molecular mechanisms underlying EBV-driven cancers.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
674
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K